Nasdaq:IMNN
#Imunon #Reports #Inducement #Grants #NASDQ #Listing #Rule LAWRENCEVILLE, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company focused...
Hi, what are you looking for?
#Imunon #Reports #Inducement #Grants #NASDQ #Listing #Rule LAWRENCEVILLE, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company focused...